The clinical importance of interstitial lung abnormality (ILA) is increasingly recognized. In
July 2020, the Fleischner Society published a position paper about ILA. The purposes of this …

Lung, breast, and esophageal cancer represent three common malignancies with high
incidence and mortality worldwide. The management of these tumors critically relies on …

The incidental discovery of pre-clinical interstitial lung disease (ILD) has led to the
designation of interstitial lung abnormalities (ILA), a radiological entity defined as the …

Background The association between interstitial lung abnormalities (ILAs) and long-term
outcomes has not been reported in Asian health screening populations. Purpose To …

Rationale: Incidental parenchymal abnormalities detected on chest computed tomography
scans are termed interstitial lung abnormalities (ILAs). ILAs may represent early interstitial …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by a progressive
decline in lung function and poor prognosis. The deposition of the extracellular matrix (ECM) …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease of pulmonary scarring. New
treatments slow disease progression and allow pulmonary fibrosis patients to live longer …

Several trials have shown that low-dose computed tomography-based lung cancer
screening (LCS) allows a substantial reduction in lung cancer-related mortality, carrying the …

Background Interstitial lung abnormalities (ILA) are CT findings suggestive of interstitial lung
disease in individuals without a prior diagnosis or suspicion of ILD. Previous studies have …

Importance Immune checkpoint inhibitor–induced interstitial lung disease (ICI-ILD) is
clinically serious and life-threatening. Preexisting interstitial lung abnormalities have been …